Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial

[1]  P. Castle,et al.  Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening , 2022, British Journal of Cancer.

[2]  M. Poljak,et al.  Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. , 2022, The Lancet. Oncology.

[3]  N. Houwing,et al.  Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review , 2022, Preventive medicine reports.

[4]  L. Richardson,et al.  Cancer Screening Prevalence and Associated Factors Among US Adults , 2022, Preventing chronic disease.

[5]  M. Hudgens,et al.  Prevalence of High-Risk Human Papillomavirus by RNA Assay in Home Self-Collected Samples Among Underscreened People in North Carolina , 2021, Sexually transmitted diseases.

[6]  M. Hudgens,et al.  High-risk Human Papillomavirus Messenger RNA Testing in Wet and Dry Self-collected Specimens for High-grade Cervical Lesion Detection in Mombasa, Kenya , 2020, Sexually transmitted diseases.

[7]  M. Hudgens,et al.  Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial , 2019, Trials.

[8]  Jasmin A. Tiro,et al.  Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment , 2019, JAMA network open.

[9]  N. Brewer,et al.  Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1. , 2019, Journal of women's health.

[10]  Jasmin A. Tiro,et al.  Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. , 2019, Journal of the National Cancer Institute.

[11]  S. Temin,et al.  Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses , 2018, British Medical Journal.

[12]  N. Brewer,et al.  Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections. , 2018, Obstetrics and gynecology.

[13]  J. Kimani,et al.  High‐risk HPV‐RNA screening of physician‐ and self‐collected specimens for detection of cervical lesions among female sex workers in Nairobi, Kenya , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[14]  M. Phipps,et al.  Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[15]  O. Carrasquillo,et al.  A randomized trial of mailed HPV self-sampling for cervical cancer screening among ethnic minority women in South Florida , 2018, Cancer Causes & Control.

[16]  Sara W. Bird,et al.  Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs , 2018, Front. Public Health.

[17]  N. Brewer,et al.  Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States , 2017, Sexually transmitted diseases.

[18]  J. Little,et al.  Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology , 2016, BMJ Open.

[19]  C. Poole,et al.  High-Risk Human Papillomavirus Messenger RNA Testing in Physician- and Self-Collected Specimens for Cervical Lesion Detection in High-Risk Women, Kenya , 2013, Sexually transmitted diseases.

[20]  Randy W. Elder,et al.  Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. , 2012, American journal of preventive medicine.

[21]  Y. Qiao,et al.  Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method , 2012, Journal of the National Cancer Institute.

[22]  H. Adami,et al.  A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  G. Guyatt,et al.  Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis , 2002, BMJ : British Medical Journal.

[24]  J. Robins,et al.  Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests , 2000, Biometrics.

[25]  Increasing Cervical Cancer Screening: Multicomponent Interventions , 2019 .

[26]  C. Forbes,et al.  Interventions targeted at women to encourage the uptake of cervical screening. , 2021, The Cochrane database of systematic reviews.

[27]  W. Shadish,et al.  Experimental and Quasi-Experimental Designs for Generalized Causal Inference , 2001 .